The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 14, 2017

Filed:

Mar. 14, 2013
Applicant:

Abbott Cardiovascular Systems, Inc., Santa Clara, CA (US);

Inventors:

Pamela A. Kramer-Brown, San Jose, CA (US);

Kayla L. Calvert, Mountain House, CA (US);

John A. Simpson, Carlsbad, CA (US);

Stephen D. Pacetti, San Jose, CA (US);

Austin M. Leach, Oakland, CA (US);

Assignee:

Abbott Cardiovascular Systems, Inc., Santa Clara, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C22C 19/07 (2006.01); A61F 2/06 (2013.01); A61L 31/02 (2006.01); A61L 31/18 (2006.01); C22C 1/04 (2006.01); C22C 19/05 (2006.01); C22C 27/00 (2006.01); C22C 27/04 (2006.01); C22C 27/06 (2006.01);
U.S. Cl.
CPC ...
A61F 2/06 (2013.01); A61L 31/022 (2013.01); A61L 31/18 (2013.01); C22C 1/0433 (2013.01); C22C 19/07 (2013.01); C22C 19/05 (2013.01); C22C 27/00 (2013.01); C22C 27/04 (2013.01); C22C 27/06 (2013.01);
Abstract

Embodiments are directed to radiopaque implantable structures (e.g., stents) formed of cobalt-based alloys that comprise cobalt, chromium and one or more platinum group metals, refractory metals, precious metals, or combinations thereof. Platinum group metals include platinum, palladium, ruthenium, rhodium, osmium, and iridium. Refractory metals include zirconium, niobium, rhodium, molybdenum, hafnium, tantalum, tungsten, rhenium, and precious metals include silver and gold. In one embodiment, the one or more included platinum group or refractory metals substitute at least partially for nickel, such that the alloy exhibits reduced nickel content, or is substantially nickel free. The stents exhibit improved radiopacity as compared to similar alloys including greater amounts of nickel.


Find Patent Forward Citations

Loading…